Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.H Michael BelmontThe New England journal of medicine(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要